Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.66 - $1.0 $252 - $382
382 Added 636.67%
442 $0
Q1 2024

Nov 05, 2024

SELL
$0.9 - $1.1 $343 - $420
-382 Reduced 86.43%
60 $0
Q1 2024

May 15, 2024

SELL
$0.9 - $1.1 $171 - $209
-190 Reduced 76.0%
60 $0
Q4 2023

Feb 14, 2024

BUY
$0.74 - $1.17 $185 - $292
250 New
250 $0
Q2 2023

Aug 14, 2023

BUY
$0.83 - $1.37 $281 - $464
339 New
339 $0
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.66 $103 - $163
35 New
35 $0
Q2 2022

Aug 15, 2022

SELL
$2.49 - $6.76 $2,430 - $6,597
-976 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.76 - $10.83 $5,875 - $11,046
-1,020 Reduced 51.1%
976 $7,000
Q4 2021

Feb 14, 2022

BUY
$9.41 - $22.19 $10,633 - $25,074
1,130 Added 130.48%
1,996 $21,000
Q3 2021

Nov 15, 2021

BUY
$17.88 - $24.8 $15,484 - $21,476
866 New
866 $16,000

Others Institutions Holding RPID

About RAPID MICRO BIOSYSTEMS, INC.


  • Ticker RPID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,389,100
  • Market Cap $39.3M
  • Description
  • Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumab...
More about RPID
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.